Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Biocept Inc (BIOC)

0.1789 -0.003 (-1.87%)

05-22 11:40

Open:

0.1892

Pre. Close:

0.1823

High:

0.1892

Low:

0.1703

Volume:

872,815

Market Cap:

12M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.19 - 0.191

0.191 - 0.192

Low:

0.177 - 0.179

0.179 - 0.18

Close:

0.178 - 0.18

0.18 - 0.182

Technical analysis  (as of: 2018-05-22 11:07:52 AM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 0.26     One year: 0.30

Support:

Support1: 0.17    Support2: 0.14

Resistance:

Resistance1: 0.23    Resistance2: 0.26

Pivot:

0.21

Moving Averages:

MA(5): 0.19     MA(20): 0.21

MA(100): 0.35     MA(250): 0.83

MACD:

MACD(12,26): -0.02     Signal(12,26,9): -0.02

%K %D:

%K(14,3): 16.67     %D(3): 26.19

RSI:

RSI(14): 27.52

52-Week:

High: 1.64  Low: 0.17  Change(%): -88.2

Average Vol(K):

3-Month: 228548  10-Days 108124

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BIOC has closed above bottom band by 0.8%. Bollinger Bands are 54.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to BIOC's normal range. The bands have been in this narrow range for 67 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-16T06:58:20-04:00
Mixed shelf filing roundup

2018-05-15T19:20:05-04:00
Biocept's (BIOC) CEO Michael Nall on Q1 2018 Results - Earnings Call Transcript

2018-05-15T16:07:12-04:00
Biocept misses by $0.02, misses on revenue

2018-05-15T16:05:00-04:00
Biocept Reports First Quarter 2018 Financial Results

2018-05-08T08:05:00-04:00
Biocept to Release First Quarter 2018 Financial Results and Host Investor Conference Call on May 15, 2018

2018-05-01T08:05:00-04:00
Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for Patient Diagnosed with Non-Small Cell Lung Cancer

2018-04-27T08:05:00-04:00
Published Case Study Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for ALK Rearrangements

2018-04-06T08:05:00-04:00
Biocept to Webcast Presentation at the 7th Annual MicroCap Conference

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Diagnostic Testing Substances

Shares Out. (M)

68.04

Shares Float (M)

67.51

% Held by Insiders

0.80

% Held by Institutions

23.10

Shares Short (K)

5684

Shares Short Prior Month (K)

2540

Stock Financials

EPS

-0.800

EPS Est. Current Year

-0.790

EPS Est. Next Year

-0.660

EPS Est. Next Quarter

-0.190

Forward EPS

-0.219

Book Value (p.s.)

11.290

PEG Ratio

-0.02

Profit Margin

Operating Margin

-417.76

Return on Assets (ttm)

-289.0

Return on Equity (ttm)

-2211.5

Qtrly Rev. Growth

-22.9

Gross Profit (p.s.)

-0.043

Sales Per Share

EBITDA (p.s.)

-0.223

Qtrly Earnings Growth

Operating Cash Flow (M)

-19.65

Levered Free Cash Flow (M)

-13.16

atoplab.com

Valuation

P/E

-0.22

P/E Growth Ratio

-0.03

P/BV

0.02

P/S

62668424.00

P/CF

-0.61

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-09-29

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.